Mercator Medsystems
US-based Mercator MedSystems creates targeted delivery devices for vascular, oncologic, and regenerative treatments.
Founded
2000US-based Mercator MedSystems creates targeted delivery devices for vascular, oncologic, and regenerative treatments.
Founded in San Leandro, United States, Mercator MedSystems develops targeted delivery devices aimed at treating vascular, oncologic, and regenerative diseases. The company's core mission is to enhance patient outcomes through innovative site-specific therapies. Their flagship product, the Bullfrog Micro-Infusion Device, is designed to deliver therapeutic agents directly to affected tissues, offering applications in conditions such as deep vein thrombosis and restenosis. Mercator MedSystems focuses on advancing medical treatments through precision and efficacy.
Notable figures associated with Mercator MedSystems include a seasoned management team and a board of directors with extensive experience in the medical device industry. The company has secured investments from prominent healthcare venture capital firms. Key achievements include successful clinical trials, such as the phase-one trial assessing anti-inflammatory drugs for acute deep vein thrombosis. Overall, Mercator MedSystems has significantly impacted the field of targeted medical therapies, contributing to improved treatment methodologies and patient care.
Companies similar to Mercator Medsystems include Mercury Biomed, Micro Medical Solutions, Liquet Medical and Vascular Designs.
Mercator Medsystems was founded in 2000.
Mercator Medsystems' headquarters is located in San Leandro, CA, US.
Mercator Medsystems' most recent funding round was for $14.3M (USD) in June 2019.
As of Jun 13, 2019, Mercator Medsystems has disclosed funding of $23.3M (USD). Undisclosed round amounts are excluded.
Mercator Medsystems has 16 employees as of Feb 5, 2024.
Vascular Designs
